MSLN and pleural mesothelioma: Specifically, in pleural mesothelioma (PM), the accuracy of MSLN as a biomarker has been evaluated across different matrices (mostly serum, plasma, and pleural fluids) and among different groups of individuals (mesothelioma patients, individuals affected by benign respiratory diseases, and healthy subjects).